Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMISULPRIDE Cause Therapeutic product effect variable? 147 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Therapeutic product effect variable have been filed in association with AMISULPRIDE (Barhemsys). This represents 4.7% of all adverse event reports for AMISULPRIDE.

147
Reports of Therapeutic product effect variable with AMISULPRIDE
4.7%
of all AMISULPRIDE reports
0
Deaths
147
Hospitalizations

How Dangerous Is Therapeutic product effect variable From AMISULPRIDE?

Of the 147 reports, 147 (100.0%) required hospitalization, and 1 (0.7%) were considered life-threatening.

Is Therapeutic product effect variable Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 147 reports have been filed with the FAERS database.

What Other Side Effects Does AMISULPRIDE Cause?

Drug ineffective (665) Weight increased (346) Toxicity to various agents (305) Suicide attempt (261) Akathisia (252) Extrapyramidal disorder (226) Drug abuse (219) Leukopenia (218) Therapeutic product effect incomplete (200) Off label use (191)

What Other Drugs Cause Therapeutic product effect variable?

CARBIDOPA\LEVODOPA (316) LEVODOPA (298) RIMEGEPANT (177) GABAPENTIN (166) CLOZAPINE (157) DICLOFENAC (153) OLANZAPINE (150) FLUOXETINE (149) ARIPIPRAZOLE (148) LOXAPINE (147)

Which AMISULPRIDE Alternatives Have Lower Therapeutic product effect variable Risk?

AMISULPRIDE vs AMITRIPTYLINE AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE AMISULPRIDE vs AMIVANTAMAB AMISULPRIDE vs AMIVANTAMAB-VMJW AMISULPRIDE vs AMLODIPINE

Related Pages

AMISULPRIDE Full Profile All Therapeutic product effect variable Reports All Drugs Causing Therapeutic product effect variable AMISULPRIDE Demographics